New Zealand To Cover First Hep C Drug In Decade, Merck's Victrelis
This article was originally published in PharmAsia News
Executive Summary
New Zealand's Pharmac has decided to cover Merck Sharp Dohme's Victrelis (boceprevir) for chronic hepatitis C beginning Sept. 1.